Refractory, primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Also known as: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB05015Belinostat1Recruiting1
DB05015Belinostat1Suspended1
DB08870Brentuximab vedotin1Withdrawn1
DB08889Carfilzomib1Suspended1
DB14707Cemiplimab1Recruiting1
DB12483Copanlisib1Suspended1
DB00531Cyclophosphamide1Recruiting2
DB09331Daratumumab1Suspended1
DB01073Fludarabine1Recruiting1
DB09502Fludeoxyglucose (18F)1Suspended1
DB13134Fluorine F-181Suspended1
DB00441Gemcitabine1Suspended1
DB14999Human interferon beta1Recruiting1
DB06186Ipilimumab1Recruiting1
DB00480Lenalidomide1Withdrawn1
DB12498Mogamulizumab1Recruiting1
DB15721Natural Killer Cell1Recruiting1
DB09035Nivolumab1Recruiting1
DB09035Nivolumab1Suspended1
DB08935Obinutuzumab1Suspended1
DB14867Parsaclisib1Recruiting1
DB09037Pembrolizumab1Suspended1
DB00073Rituximab1Suspended1
DB06176Romidepsin1Active Not Recruiting1
DB06176Romidepsin1Recruiting1
DB06176Romidepsin1Suspended1
DB11119Sodium iodide1Recruiting1
DB12887Tazemetostat1Recruiting1
DB00072Trastuzumab1Suspended1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB06176Romidepsin1 / 2Active Not Recruiting1
DB08870Brentuximab vedotin2Active Not Recruiting1
DB00480Lenalidomide2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB13896Talimogene laherparepvec2Active Not Recruiting1